Penumbra Inc

NYSE:PEN   3:59:59 PM EDT
-9.69 (-3.91%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)8.55B
Current PE285.95
Forward PE 276.62
2yr Forward PE 185.85
See more stats
Estimates Current Quarter
Revenue$194.3 Million
Adjusted EPS$0.19
See more estimates
10-Day MA$249.79
50-Day MA$265.60
200-Day MA$270.04
See more pivots

Penumbra Inc Stock, NYSE:PEN

One Penumbra Place, Alameda, California 94502
United States of America
Phone: +1.510.748.3200
Number of Employees: 3300


Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers thrombectomy, embolization, access, neurosurgical tools, ruby coil system, lantern, penumbra occlusion device (POD) system, packing coil, and indigo systems products. Its target markets include interventional neuroradiologists, neurosurgeons, and interventional neurologists; and interventional radiologists, vascular surgeons, and interventional cardiologists. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004 and is headquartered in Alameda, CA.